Status:

RECRUITING

Eosinophil-guided Reduction of Inhaled Corticosteroids

Lead Sponsor:

Chronic Obstructive Pulmonary Disease Trial Network, Denmark

Conditions:

COPD

Inhaled Corticosteroid

Eligibility:

All Genders

40+ years

Phase:

PHASE4

Brief Summary

Clinical trial on eosinophil-guided time-updated person-specific reduction of inhaled corticosteroid (ICS) therapy and prophylactic azithromycin therapy in patients with severe or very severe chronic ...

Detailed Description

Inhaled corticosteroid (ICS) treatment is recommended by Global Initiative for Obstructive Lung Disease (GOLD) for patients with frequent and/or servere exacerbations and blood eosinophils \> 0.3 x 10...

Eligibility Criteria

Inclusion

  • COPD (verified by a specialist in respiratory medicine + spirometry)
  • GOLD class E anytime within the last 2 years (corresponding to 2 ≥ AECOPD and/or ≥1 AECOPD leading to hospitalization during a 12 months period within the last 2 years) and/or FEV1\<30%.
  • Treatment for last 4 weeks including LAMA, LABA and ICS
  • Informed consent

Exclusion

  • Known asthma.
  • Male \< 40 years.
  • Female \<40 years, if non-menopausal (had menstruation within the last 12 months) conditioned by a negative urine HCG test
  • Severe mental illness which considerably complicates co-operation.
  • Language problems that considerably complicate co-operation.
  • Current treatment with systemic corticosteroids corresponding to \> 5 mg prednisolone per day.
  • Systemic antibiotic treatment (if to participate in microbiota sub-study) or systemic corticosteroid treatment within 14 days (also prophylactic Azithromycin).
  • Contra-indication to treat with Azithromycin (as listed by the producer).
  • Non-bacterial exacerbation per investigator judgement in the last 3 months.

Key Trial Info

Start Date :

June 28 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

444 Patients enrolled

Trial Details

Trial ID

NCT04481555

Start Date

June 28 2021

End Date

December 31 2026

Last Update

March 13 2025

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

Aarhus University Hospital

Aarhus, Denmark

2

Hvidovre Hospital

Copenhagen, Denmark

3

Sydvestjysk Sygehus Esbjerg

Esbjerg, Denmark

4

Gentofte Hospital

Hellerup, Denmark